TORONTO, ON — January 7, 2026 — Leads & Copy — AI/ML Innovations Inc. has appointed Erik Suokas as its new Chief Operating Officer. The appointment is intended to bolster the company’s commercial execution and operational scale as it advances its AI-driven cardiac platform.
Suokas will be responsible for overseeing day-to-day operations, focusing on commercial strategy, contract discipline, delivery readiness, and cross-functional alignment. He will collaborate with Executive Chairman & Chief Executive Officer Paul Duffy, and Chief Product Officer Esmat Naikyar, to convert commercial momentum into revenue and scalable delivery.
According to the company, AIML is transitioning from platform development and validation to revenue execution, customer delivery, and operational scale. The appointment of a COO reflects the company’s focus on combining innovation with disciplined execution as it expands its commercial relationships across clinical, wellness, and enterprise health markets.
Suokas brings over 20 years of leadership experience in healthcare, MedTech, SaaS, and regulated clinical environments. Prior to joining AIML, he served as National Director at Sun Nuclear North America, where he launched the Canadian direct-sales organization and drove revenue growth by approximately 200% in under two years.
Earlier in his career, Suokas held senior commercial and operational roles at Canadian Orthodontic Partners, Abbott Medical, St. Jude Medical, Align Technology, and Medtronic. His experience includes cardiology, diagnostics, enterprise healthcare procurement, and regulated market delivery.
Suokas holds a Doctor of Chiropractic (DC), Juris Doctor (JD), and MBA.
Paul Duffy, Executive Chairman and CEO of AIML, said Suokas’s experience in complex healthcare environments would bring clarity, leadership, and operational accountability.
Suokas said he was excited about the opportunity to translate AIML’s innovation into customer outcomes, secure revenue, support delivery, and build the operating systems that allow the company to scale.
Esmat Naikyar, Chief Product Officer of AIML, said Suokas’s understanding of healthcare customers, delivery expectations, and operational constraints would ensure product innovation continues to translate into real-world impact as the company grows.
As Chief Operating Officer, Suokas will focus on strengthening AIML’s operating backbone, ensuring commercial agreements are delivery-ready, aligning product commitments with execution capacity, and building cadence across teams.
AIML Innovations Inc. pioneers the use of artificial intelligence and neural networks to transform digital health.
Blake Fallis (778) 405-0882
Source: AI/ML Innovations Inc.
